Ratings L'Oréal

Equities

Market Closed - Euronext Paris Other stock markets 12:36:08 2025-03-14 EDT			5-day change	1st Jan Change
366.90 ^EUR	+3.40%		+2.04%	+7.33%

03-12	Brussels has made EU liquor, beauty exports trade war targets, industries say	RE
03-11	Persil-owner Henkel gives soft growth guidance, as weak North America weighs	RE

The company presents an interesting fundamental situation from a short-term investment perspective.
According to MSCI, the company's ESG score for its industry is good.

The group's high margin levels account for strong profits.
Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.

With an expected P/E ratio at 30.83 and 28.38 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
With an enterprise value anticipated at 4.61 times the sales for the current fiscal year, the company turns out to be overvalued.
The company appears highly valued given the size of its balance sheet.
The valuation of the company is particularly high given the cash flows generated by its activity.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
The average consensus view of analysts covering the stock has deteriorated over the past four months.

Source: Surperformance

Source: MSCI

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Fundamentals	Valuation	Revisions of Fundamental Estimates	Capi.($)
	L'ORÉAL				213B
	GALDERMA GROUP AG				24.19B
	KAO CORPORATION				20.23B
	SHISEIDO COMPANY, LIMITED				7.65B
	PROYA COSMETICS CO.,LTD.				4.81B
	COTY INC.				4.8B
	AMOREPACIFIC CORPORATION				4.78B
	INTERPARFUMS				3.42B
	YUNNAN BOTANEE BIO-TECHNOLOGY GROUP CO.LTD				2.76B
	Average				31.77B
	Weighted average by Cap.